Your browser doesn't support javascript.
loading
Reduced-dose post-transplant cyclophosphamide plus low-dose post-transplant anti-thymocyte globulin as graft-versus-host disease prophylaxis with fludarabine-busulfan-cytarabine conditioning in haploidentical peripheral blood stem cell transplantation: A multicentre, randomized controlled clinical trial.
Zhang, Wenli; Gui, Ruirui; Zu, Yingling; Zhang, Binglei; Li, Zhen; Zhang, Yanli; Wang, Xianjing; Guo, Shuli; Zhan, Xinrong; Fu, Yuewen; Song, Yongping; Zhou, Jian.
Afiliación
  • Zhang W; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Gui R; Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.
  • Zu Y; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Zhang B; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Li Z; Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.
  • Zhang Y; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Wang X; Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.
  • Guo S; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Zhan X; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Fu Y; Department of Hematology, The Third People's Hospital of Zhengzhou, Zhengzhou, China.
  • Song Y; Department of Hematology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, China.
  • Zhou J; Department of Hematology, Xinxiang Central Hospital, Xinxiang, China.
Br J Haematol ; 200(2): 210-221, 2023 01.
Article en En | MEDLINE | ID: mdl-36200642

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Trasplante de Células Madre de Sangre Periférica / Enfermedad Injerto contra Huésped Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Br J Haematol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Trasplante de Células Madre de Sangre Periférica / Enfermedad Injerto contra Huésped Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Br J Haematol Año: 2023 Tipo del documento: Article País de afiliación: China